Protein overexpression and gene amplification of c-erbB-2 in breast carcinomas: A comparative study of immunohistochemistry and fluorescence in situ hybridization of formalin-fixed, paraffin-embedded tissues

Human Pathology

Volumn 33, Issue 1, 2002, Pages 21-28

  Kobayashi, Masako ^a,b   Ooi, Akishi ^a,b   Oda, Yoshio ^a,b   Nakanishi, Isao ^a,b  

^a KANAZAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Breast cancer; c erbB 2; Fluorescence in situ hybridization; Intraductal spread

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; FORMALDEHYDE; GENE PRODUCT; PARAFFIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CANCER INVASION; CANCER SCREENING; CARCINOMA CELL; CHROMOSOME 17; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE OVEREXPRESSION; GENE PROBE; GENETIC HETEROGENEITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; ONCOGENE C ERB; TISSUE FIXATION;

EID: 0036151864     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2002.30185     Document Type: Article

References (35)

1. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene
2. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer
3. HER-2/neu (c-erb-B2) gene and protein in breast cancer
4. Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer
5. Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer
6. Multiple developmental pathways of highly aggressive breast cancers disclosed by comparison of histological grades and c-erbB-2 expression patterns in both the non-invasive and invasive portions
7. Intraductal spread of invasive breast carcinoma has a positive correlation with c-erbB-2 overexpression and vascular invasion
8. Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: A direct comparison of fluorescence in situ hybridization and immunohistochemistry
9. HER-2/neu testing in breast carcinoma: A combined immunohistochemical and fluorescence in situ hybridization approach
10. Laboratory assessment of the status of Her-2/neu protein and oncogene in breast cancer specimens: Comparison of immunohistochemistry assay with fluorescence in situ hybridisation assays
11. HER-2/neu gene amplification compared with HER-2/neu protein overexpression and interobserver reproducibility in invasive breast carcinoma
12. Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization
13. Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer
14. Strong correlation between results of fluorescent in situ hybridization and immunohistochemistry for the assessment of the ERBB2 (HER-2/neu) gene status in breast carcinoma
15. Fluorescence in situ hybridization (FISH) for detection of HER-2/neu amplification in breast cancer: A multicenter portability study
16. Genetic alterations in early-onset invasive breast carcinomas: Correlation of c-erbB-2 amplification detected by fluorescence in situ hybridization with p53 accumulation and tumor phenotype
17. Fluorescence in situ hybridisation detection of erbB 2 amplification in breast cancer fine needle aspirates
18. c-erbB2/neu gene and chromosome 17 analysis in breast cancer by FISH on archival cytological fine-needle aspirates
19. Quantitation of HER-2/neu and c-myc gene amplification in breast carcinoma using fluorescence in situ hybridization
20. Fluorescence in situ hybridization for detecting erbB-2 amplification in breast tumor fine needle aspiration biopsies
21. Determination of Her-2/neu status in breast carcinoma: Comparative analysis of immunohistochemistry and fluorescent in situ hybridization
22. c-erbB-2 over-expression in amplified and non-amplified breast carcinoma samples
23. HER-2/neu gene amplification characterized by fluorescence in situ hybridization: Poor prognosis in node-negative breast carcinomas
24. FISH detection of HER-2/neu oncogene amplification in early onset breast cancer
25. Histological grading and prognosis in breast cancer
26. Pathologic predictors of early local recurrence in stage I and II Breast cancer treated by primary radiation therapy
27. Amplification of the c-erbB-2 (HER-2/neu) gene in gastric cancer cells
28. Amplification of c-erbB-2 in gastric cancer: Detection in formalin-fixed, paraffin-embedded tissue by fluorescence in situ hybridization
29. Amplification units and translocation at chromosome 17q and c-erbB-2 overexpression in the pathogenesis of breast cancer
30. Unconjugated monoclonal antibodies for the treatment of hematologic and solid malignancies
31. erbB2protein is localized on cell organelles involved in cell motility
32. Evaluation of HER-2 neu oncoprotein expression as a prognostic indicator of local recurrence in conservatively treated breast cancer: A case-control study
33. Immunohistochemical assay of neu/c-erbB-2 oncogene product in paraffin-embedded tissues in early breast cancer: Retrospective follow-up study of 245 stage I and II cases